Why, Who, When, Where and More: New Draft Guidance on Notifying FDA about Discontinuance or Interruption in Manufacturing
FDA Law
MARCH 4, 2024
By Véronique Li, Senior Medical Device Regulation Expert & Deborah L. API and its source and any alternative sources; associated medical devices), and expected duration of the interruption. blood supply; and, Manufacturers of certain finished drug products marketed without an approved NDA or ANDA.
59 
Let's personalize your content